Journal of Immunotherapy (Hagerstown, Md. : 1997)
-
Publication Venue For
-
Dendritic cell-based immunotherapy in prevention and treatment of renal cell carcinoma: efficacy, safety, and activity of Ad-GM·CAIX in immunocompetent mouse models..
36:102-111.
2013
-
Phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma..
30:749-761.
2007
-
Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901..
29:95-101.
2006
-
Workshop on cancer biometrics: identifying biomarkers and surrogates of cancer in patients: a meeting held at the Masur Auditorium, National Institutes of Health..
28:79-119.
2005
-
Enumerating antigen-specific T-cell responses in peripheral blood: a comparison of peptide MHC Tetramer, ELISpot, and intracellular cytokine analysis..
28:63-72.
2005
-
Human gammadelta T cells from G-CSF-mobilized donors retain strong tumoricidal activity and produce immunomodulatory cytokines after clinical-scale isolation..
28:73-78.
2005
-
Comparative analysis of antigen loading strategies of dendritic cells for tumor immunotherapy..
27:265-272.
2004
-
Intraperitoneal fluid neopterin, nitrate, and tryptophan after regional administration of interleukin-12..
26:270-276.
2003
-
Characterization of CD8(-) HLA class I/epitope tetrameric complexes binding T cells..
25:379-384.
2002
-
Frequency of MART-1/MelanA and gp100/PMel17-specific T cells in tumor metastases and cultured tumor-infiltrating lymphocytes..
25:252-263.
2002
-
Dendritic cells cultured in anti-CD40 antibody-immobilized plates elicit a highly efficient peptide-specific T-cell response..
25:176-184.
2002
-
Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy..
25:97-138.
2002
-
Laser scanning cytometry evaluation of MART-1, gp100, and HLA-A2 expression in melanoma metastases..
24:447-458.
2001
-
Cytokines and immune response in the tumor microenvironment..
24:392-407.
2001
-
Induction of cytotoxic T lymphocytes with dendritic cells transfected with human papillomavirus E6 and E7 RNA: implications for cervical cancer immunotherapy..
23:412-418.
2000
-
Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100..
23:487-498.
2000
-
The role of IL-13 in the generation of dendritic cells in vitro..
22:506-513.
1999
-
Induction of primary, human antigen-specific cytotoxic T lymphocytes in vitro using dendritic cells pulsed with peptides..
21:32-40.
1998
-
Active immunization with tumor cells transduced by a novel AAV plasmid-based gene delivery system..
20:26-37.
1997
-
Targeting Soluble Tumor Associated Antigens CEA and HER2 to Exosomes Enhances Antigen Specific Immune Reponses
2010
-
Effect of Cryopreservation on Assays of Antigen-Specific T Cells: Comparison of Tetramer, Cytokine Flow Cytometry, and ELISPOT
2004
-
Maximizing the Retention of Antigen Specific Lymphocyte Function after Cryopreservation
2004